CoMentis' Other Investors

CoMentis raised a round of funding on , .

CoMentis is focused on developing drugs to treat various central nervous system (CNS) disorders such as Alzheimer's disease and schizophrenia. The company covers the research and development spectrum …

Articles about CoMentis' Other Investors: